1.Improvement of heat-tolerance by training I. Evaluation of effects of long-distance running and march training on heat-tolerance
Improvement of heat－tolerance by training I．Evaluation of effects of long－distance running and march training on heat－toleran
2.Improvement of heat-tolerance by training I. Evaluation of effects of combined of march and cross-country race on heat-tolerance
Improvement of heat－tolerance by training Ⅲ． Evaluation of effectsofcombined training of march and cross－country race on heat
3.EFFECT OF CHRONIC ACE INHIBITION ON GLUCOSE TOLERANCE AND INSULIN SENSITIVITY IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS
EFFECT OF CHRONIC ACE INHIBITIONONGLUCOSE TOLERANCE AND INSULIN SENSITIVITY IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS
4.objective To investigate the clinical effect of rosiglitazone in the patients with impairedglucose tolerance(IGT) or impaired fasting glucose(IFG).
目的探讨文迪雅(罗格列酮)对糖耐量减低(impaired glucose tolerance,IGT)或空腹血糖损害(impaired fasting glucose,IFG)(糖稳态受损)患者临床干预治疗的效果。
5.One of them,designatedas stg2(salt tolerance during germination 2) was studied.
本文中对其中的一株耐盐突变体,命名为stg2(salt tolerance during germination 2),进行了研究。
6.The mechanism of brain ischemic tolerance (BIT) induced by cerebral ischemic preconditioning (CIP) involves cascades of events including release of neurotransmitter, activation of receptors and gene expression.
脑缺血预处理（cerebral ischemic preconditioning，CIP）诱导的脑缺血耐受（brain ischemic tolerance，BIT）的产生涉及神经介质、受体及基因的表达等一系列过程。
7.All had 24-hour noninvasive ambulance blood pressure (ABP) monitoring, 75-g oral glucose tolerance test (OGTT) and Echocardiagraphic study. We determined fasting glucose ,fasting plasma insulin and postload glucose and plasma insulin 2 hours after in taking 75-g glucose.
分别测定身高、体重并计算体重指数(body mass index，BMI)、测定血脂，24小时动态血压监测(24-hour noninvasive ambulatory blood press，ABP)，口服葡萄糖耐量(75g oral glucose tolerance test，OGTT)和胰岛素释放试验，超声心动图检查心脏结构和左室舒张功能。
8.Result The graft mean survival time(MST) in the portal venous tolerance group、the oral tolerance group were 15.8±2.1d, 13.0±1.3d respectively,significantly longer than that in the control group（P＜0.01）； MST in the portal venous tolerance group was significantly longer than that in the oral tolerance （P＜0.01）.
结果：移植皮肤的平均存活时间（MST）门静脉耐受诱导组为15.8±2.1天,口服耐受诱导组为13.0±1.3天,均较对照组长（P＜0.01），组间MST比较门静脉耐受诱导组比口服耐受诱导组长（P＜0.01）。
9.ObjectiveTo investigate the difference in risks for vascular diseases by comparing urinary albumin excretion (UAE) and prevalence of microalbuminuria (MAU) in subjects with various types of glucose tolerance including normal glucose tolerance (NGT), isolated impaired fasting glucose (I-IFG),isolated impaired glucose tolerance (I-IGT), impaired glucose tolerance combined with impaired fasting glucose (IGT/IFG) and newly diagnosed type 2 diabetes mellitus (T2 DM).
目的 比较糖耐量正常 (NGT)、单纯空腹血糖受损 (I IFG)、单纯糖耐量低减 (I IGT)、糖耐量低减合并空腹血糖受损 (IGT/IFG)、新诊断的 2型糖尿病 (2型DM ) 5种不同糖代谢状态的尿白蛋白排泄率 (UAE)和微量白蛋白尿 (MAU )患病率。
10.Methods Given 75 gram oral glucose tolerance and true insulin, insulin(INS), C peptide releasing tests in 99 cases including 30 impaired glucose tolerance (IGT group),30 normal glucose tolerance (NGT group)and 39 type 2 diabetes mellitus (DM group).
方法 对 99例患者 [IGT3 0例 ,糖耐量正常 ( NGT) 3 0例 ,2型糖尿病 ( DM) 3 9例 ]行口服葡萄糖耐量试验( OGTT)及真胰岛素 ( TI)、胰岛素 ( INS)、C肽 ( CP)释放试验。
